- Forums
- ASX - By Stock
- RAC
- Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene, page-3
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.61 |
Change
0.023(1.42%) |
Mkt cap ! $272.6M |
Open | High | Low | Value | Volume |
$1.59 | $1.61 | $1.58 | $120.1K | 75.34K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 7807 | $1.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.62 | 28 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 7807 | 1.600 |
2 | 6202 | 1.595 |
2 | 10000 | 1.590 |
2 | 11200 | 1.585 |
1 | 650 | 1.575 |
Price($) | Vol. | No. |
---|---|---|
1.620 | 28 | 1 |
1.625 | 8695 | 2 |
1.630 | 2000 | 1 |
1.640 | 280 | 1 |
1.645 | 1 | 1 |
Last trade - 11.57am 15/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online